SPYRE THERAPEUTICS INC (SYRE) Stock Cash Flow
USA - NASDAQ:SYRE - US00773J2024 - Common Stock
15.98 USD
-0.48 (-2.92%)
15.98 USD
0 (0%)
| 2024 (2024-12-31) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | 2020 (2020-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| CASH FLOWS FROM OPERATING ACTIVITIES | ||||||||
| Net Income | -208.02M | -338.79M | -83.82M | -65.80M | -80.89M | |||
| Depreciation Amortization | 0.00 | 744.00K | 1.57M | 1.58M | 1.00M | |||
| Change In Working Capital | -4.53M | -5.21M | -5.50M | 1.83M | -2.54M | |||
| Other non cash items | 55.14M | 243.34M | 7.61M | 8.68M | 6.66M | |||
| OPERATING CASH FLOW | -157.41M | -99.91M | -80.14M | -53.72M | -75.78M | |||
| CASH FLOWS FROM INVESTING ACTIVITIES | ||||||||
| Capital Expenditure | 0.00 | 0.00 | -40.00K | -570.00K | -4.28M | |||
| Other Investing Activity | -353.29M | -108.39M | 57.05M | -22.05M | -3.32M | |||
| INVESTING CASH FLOW | -353.29M | -108.39M | 57.01M | -22.62M | -7.60M | |||
| CASH FLOWS FROM FINANCING ACTIVITIES | ||||||||
| Debt Issued/Reduced | 0.00 | -16.00K | -420.00K | -510.00K | -20.00K | |||
| Stock Issued/Repurchased | 412.74M | 366.88M | 43.10M | 1.90M | 154.53M | |||
| Other Financing Activity | -1.84M | -5.79M | N/A | N/A | N/A | |||
| FINANCING CASH FLOW | 410.91M | 361.08M | 42.68M | 1.39M | 154.51M | |||
| Exchange Rate Effect | -3.00K | 25.00K | -110.00K | -20.00K | 50.00K | |||
| CHANGE IN CASH | -99.79M | 152.80M | 19.44M | -74.97M | 71.18M | |||
| FREE CASH FLOW | ||||||||
| Operating Cash Flow | -157.41M | -99.91M | -80.14M | -53.72M | -75.78M | |||
| Capital Expenditure | 0.00 | 0.00 | -40.00K | -570.00K | -4.28M | |||
| FREE CASH FLOW | -157.41M | -99.91M | -80.18M | -54.29M | -80.06M | |||
All data in USD